Fluid-attenuated inversion recovery hypointensity of the pulvinar nucleus of patients with Alzheimer disease: Its possible association with iron accumulation as evidenced by the T2* map

Korean Journal of Radiology

Volumn 13, Issue 6, 2012, Pages 674-683

  Moon, Won Jin ^a   Kim, Hee Jin ^a,b   Roh, Hong Gee ^a   Choi, Jin Woo ^a   Han, Seol Heui ^a,c  

^a Konkuk University Hospital   (South Korea)

^b Hanyang University Medical Center   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

Author keywords

Alzheimer disease; Iron; Magnetic resonance imaging; Pulvinar nucleus; T2* Relaxometry; Thalamus

Indexed keywords

IRON;

AGED; ALZHEIMER DISEASE; ARTICLE; BIOACCUMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLUID ATTENUATED INVERSION RECOVERY HYPOINTENSITY; GLOBUS PALLIDUS TO CORPUS CALLOSUM SIGNAL INTENSITY RATIO; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PROSPECTIVE STUDY; PULVINAR; PULVINAR TO CORPUS CALLOSUM SIGNAL INTENSITY RATIO; PUTAMEN TO CORPUS CALLOSUM SIGNAL INTENSITY RATIO; RADIOLOGICAL PARAMETERS; SIGNAL INTENSITY; T2 RELAXOMETRY MAP; TISSUE LEVEL;

AGED; ALZHEIMER DISEASE; FEMALE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; PULVINAR;

EID: 84868324263     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2012.13.6.674     Document Type: Article

References (59)

1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297:353-356
2. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004;5:863-873
3. Dhenain M, El Tannir El Tayara N, Wu TD, Guégan M, Volk A, Quintana C, et al. Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice. Neurobiol Aging 2009;30:41-53
4. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259
5. Kuljis RO. Lesions in the pulvinar in patients with Alzheimer's disease. J Neuropathol Exp Neurol 1994;53:202-211
6. Leuba G, Saini K. Pathology of subcortical visual centres in relation to cortical degeneration in Alzheimer's disease. Neuropathol Appl Neurobiol 1995;21:410-422
7. Rizzo M, Anderson SW, Dawson J, Myers R, Ball K. Visual attention impairments in Alzheimer's disease. Neurology 2000;54:1954-1959
8. Kaas JH, Lyon DC. Pulvinar contributions to the dorsal and ventral streams of visual processing in primates. Brain Res Rev 2007;55:285-296
9. Snow JC, Allen HA, Rafal RD, Humphreys GW. Impaired attentional selection following lesions to human pulvinar: evidence for homology between human and monkey. Proc Natl Acad Sci U S A 2009;106:4054-4059
10. Zarei M, Patenaude B, Damoiseaux J, Morgese C, Smith S, Matthews PM, et al. Combining shape and connectivity analysis: an MRI study of thalamic degeneration in Alzheimer's disease. Neuroimage 2010;49:1-8
11. Willinek WA, Kuhl CK. 3.0 T neuroimaging: technical considerations and clinical applications. Neuroimaging Clin N Am 2006;16:217-228, ix
12. Sohn CH, Sevick RJ, Frayne R, Chang HW, Kim SP, Kim DK. Fluid attenuated inversion recovery (FLAIR) imaging of the normal brain: comparisons between under the conditions of 3.0 Tesla and 1.5 Tesla. Korean J Radiol 2010;11:19-24
13. Chavhan GB, Babyn PS, Thomas B, Shroff MM, Haacke EM. Principles, techniques, and applications of T2*-based MR imaging and its special applications. Radiographics 2009;29:1433-1449
14. Allkemper T, Schwindt W, Maintz D, Heindel W, Tombach B. Sensitivity of T2-weighted FSE sequences towards physiological iron depositions in normal brains at 1.5 and 3.0 T. Eur Radiol 2004;14:1000-1004
15. Aquino D, Bizzi A, Grisoli M, Garavaglia B, Bruzzone MG, Nardocci N, et al. Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 2009;252:165-172
16. Siemonsen S, Finsterbusch J, Matschke J, Lorenzen A, Ding XQ, Fiehler J. Age-dependent normal values of T2* and T2' in brain parenchyma. AJNR Am J Neuroradiol 2008;29:950-955
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
19. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414
20. Péran P, Cherubini A, Luccichenti G, Hagberg G, Démonet JF, Rascol O, et al. Volume and iron content in basal ganglia and thalamus. Hum Brain Mapp 2009;30:2667-2675
21. Allkemper T, Tombach B, Schwindt W, Kugel H, Schilling M, Debus O, et al. Acute and subacute intracerebral hemorrhages: comparison of MR imaging at 1.5 and 3.0 T-initial experience. Radiology 2004;232:874-881
22. Karaarslan E, Arslan A. Perirolandic cortex of the normal brain: low signal intensity on turbo FLAIR MR images. Radiology 2003;227:538-541
23. Bakshi R, Benedict RH, Bermel RA, Caruthers SD, Puli SR, Tjoa CW, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002;59:62-68
24. Milton WJ, Atlas SW, Lexa FJ, Mozley PD, Gur RE. Deep gray matter hypointensity patterns with aging in healthy adults: MR imaging at 1.5 T. Radiology 1991;181:715-719
25. Drayer BP, Olanow W, Burger P, Johnson GA, Herfkens R, Riederer S. Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 1986;159:493-498
26. Bowen BC, Pattany PM, Bradley WG, Murdoch JB, Rotta F, Younis AA, et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2000;21:647-658
27. Cheung G, Gawel MJ, Cooper PW, Farb RI, Ang LC, Gawal MJ. Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. Radiology 1995;194:263-270
28. Harder SL, Hopp KM, Ward H, Neglio H, Gitlin J, Kido D. Mineralization of the deep gray matter with age: a retrospective review with susceptibility-weighted MR imaging. AJNR Am J Neuroradiol 2008;29:176-183
29. Baleydier C, Mauguiere F. Anatomical evidence for medial pulvinar connections with the posterior cingulate cortex, the retrosplenial area, and the posterior parahippocampal gyrus in monkeys. J Comp Neurol 1985;232:219-228
30. Carrera E, Bogousslavsky J. The thalamus and behavior: effects of anatomically distinct strokes. Neurology 2006;66:1817-1823
31. Yeterian EH, Pandya DN. Corticothalamic connections of the posterior parietal cortex in the rhesus monkey. J Comp Neurol 1985;237:408-426
32. Schmahmann JD, Pandya DN. Anatomical investigation of projections from thalamus to posterior parietal cortex in the rhesus monkey: a WGA-HRP and fluorescent tracer study. J Comp Neurol 1990;295:299-326
33. Leh SE, Chakravarty MM, Ptito A. The connectivity of the human pulvinar: a diffusion tensor imaging tractography study. Int J Biomed Imaging 2008;2008:789539
34. Casanova C, Freeman RD, Nordmann JP. Monocular and binocular response properties of cells in the striate-recipient zone of the cat's lateral posterior-pulvinar complex. J Neurophysiol 1989;62:544-557
35. Casanova C, Merabet L, Desautels A, Minville K. Higher-order motion processing in the pulvinar. Prog Brain Res 2001;134:71-82
36. Villeneuve MY, Kupers R, Gjedde A, Ptito M, Casanova C. Pattern-motion selectivity in the human pulvinar. Neuroimage 2005;28:474-480
37. Johnson MD, Ojemann GA. The role of the human thalamus in language and memory: evidence from electrophysiological studies. Brain Cogn 2000;42:218-230
38. Braak H, Braak E. Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol 1991;81:261-268
39. Ogren MP, Mateer CA, Wyler AR. Alterations in visually related eye movements following left pulvinar damage in man. Neuropsychologia 1984;22:187-196
40. Petersen SE, Robinson DL, Keys W. Pulvinar nuclei of the behaving rhesus monkey: visual responses and their modulation. J Neurophysiol 1985;54:867-886
41. Robinson DL, Petersen SE. The pulvinar and visual salience. Trends Neurosci 1992;15:127-132
42. Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 2004;25:5-18; author reply 49-62
43. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41-51
44. Dobson J. Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Lett 2001;496:1-5
45. Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1-25
46. Ge Y, Jensen JH, Lu H, Helpern JA, Miles L, Inglese M, et al. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007;28:1639-1644
47. McNeill A, Birchall D, Hayflick SJ, Gregory A, Schenk JF, Zimmerman EA, et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008;70:1614-1619
48. Zhu WZ, Zhong WD, Wang W, Zhan CJ, Wang CY, Qi JP, et al. Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology 2009;253:497-504
49. Drayer B, Burger P, Hurwitz B, Dawson D, Cain J. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol 1987;149:357-363
50. Cross PA, Atlas SW, Grossman RI. MR evaluation of brain iron in children with cerebral infarction. AJNR Am J Neuroradiol 1990;11:341-348
51. Grisoli M, Piperno A, Chiapparini L, Mariani R, Savoiardo M. MR imaging of cerebral cortical involvement in aceruloplasminemia. AJNR Am J Neuroradiol 2005;26:657-661
52. Brar S, Henderson D, Schenck J, Zimmerman EA. Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism. Arch Neurol 2009;66:371-374
53. Braakman N, Matysik J, van Duinen SG, Verbeek F, Schliebs R, de Groot HJ, et al. Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. J Magn Reson Imaging 2006;24:530-536
54. Jack CR Jr, Garwood M, Wengenack TM, Borowski B, Curran GL, Lin J, et al. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med 2004;52:1263-1271
55. Lee SP, Falangola MF, Nixon RA, Duff K, Helpern JA. Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents. Magn Reson Med 2004;52:538-544
56. Vanhoutte G, Dewachter I, Borghgraef P, Van Leuven F, Van der Linden A. Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease. Magn Reson Med 2005;53:607-613
57. Meadowcroft MD, Connor JR, Smith MB, Yang QX. MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J Magn Reson Imaging 2009;29:997-1007
58. Yang X, Sammet S, Schmalbrock P, Knopp MV. Postprocessing correction for distortions in T2* decay caused by quadratic cross-slice B0 inhomogeneity. Magn Reson Med 2010;63:1258-1268
59. Schenck JF, Zimmerman EA. High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 2004;17:433-445